The Motley Fool Investing Philosophy: We generally recommend investors buy shares of at least 25 stocks and hold them for at least 5 years. Learn More
| 1 Year | 5 Year | 5 Year Annualized | Since IPO | |
|---|---|---|---|---|
| NTRB | +51.9% | -56.25% | -15.22% | -15% |
| S&P | +14.78% | +87.14% | +13.33% | +162% |
Nutriband, Inc. engages in the development of a portfolio of transdermal pharmaceutical products. It operates through the Pocono Pharmaceuticals and 4P Therapeutics segments. The Pocono Pharmaceuticals segment relates to a coated products manufacturing entity. The 4P Therapeutics segment performs contract research and development services. The company was founded by Gareth R. Sheridan and Serguei Melnik in 2012 and is headquartered in Orlando, FL.
No news articles found for Nutriband.
| Q4 2025 | YOY Change | |
|---|---|---|
| Revenue | $346.06K | -46.4% |
| Gross Profit | $63.03K | -64.9% |
| Gross Margin | 18.21% | -9.6% |
| Market Cap | $80.99M | 47.3% |
| Net Income | -$3,872.37K | -184.2% |
| EBITDA | -$3,837.38K | -183.5% |
Currently no data to display
Currently no data to display.
Currently no data to display.
| Q4 2025 | YOY Change | |
|---|---|---|
| Net Cash | $5.31M | -6.8% |
| Accounts Receivable | $147.56K | 34.6% |
| Inventory | 0.1 | -19.2% |
| Q4 2025 | YOY Change | |
|---|---|---|
| Long Term Debt | $97.68K | 53.3% |
| Short Term Debt | $160.34K | 17.2% |
| Q4 2025 | YOY Change | |
|---|---|---|
| Return On Assets | -121.91% | -56.9% |
| Return On Invested Capital | -77.75% | 278.0% |
| Q4 2025 | YOY Change | |
|---|---|---|
| Free Cash Flow | -$1,752.49K | -65.9% |
| Operating Free Cash Flow | -$1,752.49K | -73.6% |
| Metric | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | YoY Change |
|---|---|---|---|---|---|
| Price to Book | 6.56 | 9.48 | 15.72 | 9.52 | 115.99% |
| Price to Sales | 42.91 | 31.91 | 31.37 | 35.62 | 4.78% |
| Price to Tangible Book Value | 13.09 | 13.70 | 25.57 | 12.36 | 53.65% |
| Enterprise Value to EBITDA | -46.38 | -54.47 | -38.11 | -19.83 | -57.54% |
| Return on Equity | -162.9% | -108.0% | -98.0% | -136.1% | 68.36% |
| Total Debt | $186.35K | $282.44K | $270.35K | $258.03K | 28.70% |
No podcast episodes available.
No transcripts available.
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.
